What is Johnson & Johnson's abiomed — % change?

Johnson & Johnson (JNJ) reported abiomed — % change of 11.6% in Q4 2024.

What does abiomed — % change mean?

The percentage change in revenue for the Abiomed business unit compared to a previous period.

Abiomed — % Change

Johnson & Johnson Abiomed — % Change remained flat by 0.0% to 11.6% in Q4 2024 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2024

Last reportedQ4 2024

How to read this metric

A positive percentage indicates accelerating growth and successful integration, whereas a negative percentage suggests slowing demand or operational challenges within the segment.

Detailed definition

This metric measures the period-over-period percentage growth or decline in revenue for the Abiomed product line. It iso...

Peer comparison

Comparable to organic or segment-specific revenue growth rates reported by medical technology companies for their high-growth product lines.

Metric ID: jnj_segment_abiomed_change

Historical Data

1 years

	FY'24
Value	46.4%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's abiomed — % change?: Johnson & Johnson (JNJ) reported abiomed — % change of 11.6% in Q4 2024.
What does abiomed — % change mean?: The percentage change in revenue for the Abiomed business unit compared to a previous period.